Pakistan is being positioned as the primary mediator in the ongoing conflict between the U.S. and Iran.

This diplomatic effort is critical as the U.S. seeks to manage tensions with Tehran, but the choice of mediator has sparked a divide between U.S. legislative skepticism and regional acceptance.

Sen. Lindsey Graham (R-SC) expressed deep skepticism regarding the role of Islamabad. "I don’t trust Pakistan," Graham said [2]. Other U.S. officials have questioned the country's neutrality, citing concerns over alleged cooperation between Pakistan and Iran's military aircraft [2]. These doubts have led some officials to seek alternative mediation channels.

In contrast, Sen. Marco Rubio (R-FL) reported a different regional dynamic during a four-day visit to India in early May [1]. Rubio said that India raised no objection to Pakistan’s mediator role in the US-Iran war [1]. This lack of opposition from New Delhi suggests that India's current grievances with Islamabad are distinct from the geopolitical requirements of the U.S.-Iran negotiations.

Pakistan's strategic position is rooted in its historic ties with both Washington and Tehran [4]. Some analysts suggest these relationships put the country in a strong position to intervene in the conflict [4]. However, U.S. lawmakers continue to describe the arrangement as problematic, with some advocating for a return to the framework of the Abraham Accords [3].

Reports on the matter surfaced late last month, with key criticisms published May 27 [3]. The tension persists as the U.S. balances the need for a functional diplomatic bridge with the perceived risks of relying on a partner whose trustworthiness is under scrutiny by the Senate.

"I don’t trust Pakistan."

The friction between the U.S. Senate's distrust and India's neutrality highlights a complex diplomatic gamble. By utilizing Pakistan, the U.S. leverages a rare regional actor capable of speaking to both sides, but the internal political opposition in Washington suggests that any breakthrough mediated by Islamabad may face significant scrutiny or rejection by U.S. lawmakers.